Please login to the form below

Not currently logged in
Email:
Password:

Ad26

This page shows the latest Ad26 news and features for those working in and with pharma, biotech and healthcare.

HIV vaccine from J&J starts human trials

HIV vaccine from J&J starts human trials

In the case of J&J's vaccine, the regimen is an adenovirus serotype 26 (Ad26) vectored vaccine to prime the immune system, followed by a boost with a purified HIV

Latest news

More from news
Approximately 1 fully matching, plus 0 partially matching documents found.

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Aptus Health

Aptus Health is dedicated to advancing health engagement. The company offers end-to-end digital health engagement solutions spanning all areas of...

Latest intelligence

My MS journey: one patient's search for innovation
David Lazarus charts his journey from initial MS diagnosis in 1990 to his experience participating in innovative clinical trials, along with his advice for other patients....
Biotech profile: Tom Evans, CEO, Vaccitech.
Can UK company be first to develop a universal flu vaccine?...
The social dilemma: is it time for pharma to join the party?
Chris Ross explores why social media still isn’t trending for pharma, and how it can join in the fun...

Infographics